2023-09-20 08:16:16 ET
- Losers: ARS Pharmaceuticals SPRY -60% FDA declined to approve its epinephrine nasal spray
- Seelos Therapeutics ( SEEL ) -59% announces top line results from SLS-002 phase II study in adults with major depressive disorder at imminent risk of suicide.
- Bird Global ( BRDS ) -20% .
- Elutia ( ELUT ) -16% .
- Digital Transformation Opportunities Corp. ( DTOC ) -10% .
- Sunnova Energy International NOVA -7% announces proposed private offering of $400 million notes .
- Gorilla Technology Group GRRR -6% announces $25 Million registered direct offering of convertible preferred stock .
For further details see:
BRDS, ELUT and DTOC among pre-market losers